Filing Details

Accession Number:
0001654954-19-010741
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-13 16:24:04
Reporting Period:
2019-09-11
Accepted Time:
2019-09-13 16:24:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1540159 Edesa Biotech Inc. EDSA Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1620188 R. Frank Oakes C/O Edesa Biotech, Inc.
100 Spy Court
Markham A6 L3R 5H6
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Disposition 2019-09-11 1,809 $5.72 6,165 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. All share numbers reflect the 1-for-6 reverse split of the Issuer's common shares which occurred on June 7, 2019.